Advertisement
Bloomberg
BofA Survey ‘Screams’ Capitulation With Rally Set for Early 2023
(Bloomberg) — The sentiment on stocks and global growth among fund managers surveyed by Bank of America Corp. shows full capitulation, opening the way to an equities rally in 2023.Most Read from BloombergForecast for US Recession Within Year Hits 100% in Blow to BidenBlinken Says China Wants to Seize Taiwan on ‘Much Faster Timeline’Putin’s War Escalation Is Hastening Demographic Crash for RussiaS&P 500 Bounces Off Make-Or-Break Technical Level: Markets WrapThe Time to Buy the Dip Is Fast Approa
MarketWatch
Dow jumps nearly 600 points as investors embrace earnings
U.S. stock index futures rose sharply early Tuesday as investors welcomed another round of corporate earnings reports and calmer conditions in bond markets bolstered appetite for risk.
TheStreet.com
Nancy Pelosi’s Stock Disclosure Reveals a Surprising Outcome
U.S. lawmakers have been under the microscope lately for trading stocks in companies where they or their staff members might have some inside knowledge. The rules for buying and selling stocks were strengthened for Congress in 2012 by the Stop Trading on Congressional Knowledge Act. Developing rules about Congress members trading stocks is an ongoing process.
TheStreet.com
American Airlines Will Pay Millions Over Huge Passenger Problem
Few travel nightmares can be worse than packing small to avoid paying for a checked bag and then, upon arriving at the airport, being told that the bag is too big and needs to be checked anyway. At the same time, a recent study from IdeaWorks found that the percentage of revenue airlines derive from baggage fees has been rising steadily — 3.7% in 2019, 3.9% in 2020 and 4.6% in 2021. In February 2021, five passengers who traveled with American Airlines filed a class action lawsuit that accused the airline of incorrectly charging them baggage fees that they were not required to pay.
TipRanks
Cathie Wood Doubles Down on These 2 Innovation Stocks
Not many hedge managers have ignited as much controversy as Cathie Wood. The founder of Ark Invest has built her brand on running against the crowd. From her early embrace of tech stocks to her outspoken political conservatism, Cathie Wood has always been something of a lightning rod. Wood is staking her reputation and fortune on a belief that new technologies, and especially the way that new technologies will interact with each other, are going to completely transform our world. In her view, se
Reuters
J&J results beat estimates on cancer drug strength
The U.S. health conglomerate, which also sells medical devices and consumer health products such as Band Aid bandages and painkiller Tylenol, tightened its full-year adjusted profit forecast range. J&J has raised prices at its consumer health unit, which it expects to spin off in mid-to-late 2023, in response to surging inflation. On Tuesday, the company signaled that supply-chain pressures that pushed up costs at the unit were expected to ease next year.
Motley Fool
2 High-Yield Dividend Stocks to Buy Hand Over Fist and 1 to Avoid Like the Plague
When the curtain closes on 2022 in roughly two and a half months, Wall Street professionals and everyday investors are likely to look back on this year as one of the most trying on record. The first supercharged income stock that’s a screaming buy for value-oriented investors is pharmacy chain Walgreens Boots Alliance (NASDAQ: WBA).
Motley Fool
Which Stock Is More Likely to 5X First: AbbVie or Tilray Brands?
A major pharmaceutical company like AbbVie (NYSE: ABBV) and a rising cannabis company like Tilray Brands (NASDAQ: TLRY) operate in different industries and have several other characteristics that make proper comparisons complicated. Tilray’s smaller size and strong position in a rapidly growing industry would suggest to some that its stock has great potential to 5x in value relatively quickly. In contrast, AbbVie’s got a large pipeline of potential new pharmaceuticals its developing.
